It is widely assumed that the presence of IM assists in stratifying patients’ cancer risks, but there is evidence to suggest that this is not always the case.4, 5, 6 We have previously shown that glands that do not contain goblet cells can clonally expand, accumulate oncogenic TP53 mutations, and be the source of EA.7 This evidence concerns the gene TP53 and cancer.